13-51960145-T-C
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_000053.4(ATP7B):c.2121+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000053.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP7B | NM_000053.4 | c.2121+3A>G | splice_region_variant, intron_variant | Intron 7 of 20 | ENST00000242839.10 | NP_000044.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249164Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135164
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461140Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726910
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Wilson disease Pathogenic:7
- -
- -
- -
This sequence change falls in intron 7 of the ATP7B gene. It does not directly change the encoded amino acid sequence of the ATP7B protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has been observed in individual(s) with Wilson disease (PMID: 16283883, 19371217, 23518715, 24668339, 31708252). ClinVar contains an entry for this variant (Variation ID: 552579). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 7 and introduces a premature termination codon (PMID: 19371217). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. -
- -
This variant was detected in multiple individuals with Wilson disease, and was compound heterozygous (in trans) with a pathogenic variant in at least one individual, which is consistent with autosomal recessive inheritance (PMID: 16283883, 19371217, 23518715, 24668339, 31708252). It is rare in large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant is predicted to be deleterious by in silico analysis. Functional analysis suggests that this variant results in skipping of exon 7, which is expected to result in loss of function due to nonsense-mediated decay (PMID: 19371217). -
Variant summary: ATP7B c.2121+3A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Two predict the variant abolishes the canonical 5' splicing donor site. Two predict the variant weakens the canonical 5' donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (Lovicu_2009). The variant allele was found at a frequency of 4e-06 in 249164 control chromosomes (gnomAD). c.2121+3A>G has been reported in the literature in individuals affected with Wilson Disease (examples: Gromadzka_2005, Lovicu_2009, Coffey_2013, Litwin_2014 ). These data indicate that the variant may be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 31708252, 23518715, 16283883, 24668339, 19371217). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at